Skip to content

The Rise of Chinese Biosimilars

The Chinese healthcare market has transformed dramatically in the past few years. This is best seen in the growth of the biosimilars market.

Share:

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

Here at Hamden we track the market demand closely, while connecting with top market players on a daily basis.

Biosimilars market is a true challenge in China, especially at the phase of commercial manufacturing.

Contact our consultant Monika, if you’d like to hear about phenomenal industry-changing jobs or if you need to secure the best senior talents in the industry.

Monika Naturalna – 莫恩妍
Associate- Life Sciences
+44 (0) 203 167 6042 / +65 (0) 315 827 51

Click here to read more on the article

Make an enquiry

    Service:

    Industry:


    Send your CV